AIMZ Investment Advisors LLC Lowers Stock Holdings in Johnson & Johnson (NYSE:JNJ)

According to the latest filing with the Securities and Exchange Commission (SEC), AIMZ Investment Advisors LLC reduced its ownership of Johnson & Johnson (NYSE: JNJ) stocks by 0.7% during the fourth quarter of 2020. The investment firm held a total of 14,549 shares of JNJ after selling 99 shares during the reported period.

Johnson & Johnson is a multinational corporation that specializes in various industries, including pharmaceuticals, medical devices, and consumer packaged goods. The company is headquartered in New Brunswick, New Jersey, and is one of the world's leading healthcare companies.

AIMZ Investment Advisors LLC is a registered investment advisor based in New York, New York, with over $3 billion in assets under management as of December 31, 2020. The firm follows a fundamental investment approach and manages several equity portfolios for its clients.

The sale of 99 shares of JNJ stock by AIMZ Investment Advisors LLC represents a relatively small portion of the company's overall holdings. However, it is essential to note that this information alone does not provide insight into the reasons behind the sale or the investment firm's overall sentiment towards JNJ.

Johnson & Johnson's stock price has experienced significant volatility over the past year due to various factors, including the ongoing COVID-19 pandemic, regulatory issues, and product recalls. The company's stock price has risen steadily since the beginning of the year, with a current market capitalization of over $450 billion as of March 2021.

Investors and analysts will be closely monitoring JNJ's financial performance and regulatory developments, particularly regarding the ongoing legal challenges related to its talcum powder products and the COVID-19 vaccine, as these factors could impact the company's stock price and the investment strategies of firms like AIMZ Investment Advisors LLC.